Observational studyFrontiers in immunology2026
Analysis of 33,616 urinary stone cases: novel findings on renal transplantation impact, comorbidity profiles, and composition patterns.
Observational study in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum issued
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Urinary stone composition in renal transplant recipients remains poorly characterized, despite their distinct metabolic and urological profiles. Understanding stone composition patterns in this population is crucial for targeted management and recurrence prevention strategies. Methods: This retrospective observational study analyzed 33,616 urinary stone samples from two hospitals in Southern China (April 2014-December 2024). We compared stone composition between 69 renal transplant recipients with nephrolithiasis and 33,547 non-transplant stone-forming controls using Fourier Transform-Infrared Spectrometry. Propensity score matching (1:2) was performed to balance baseline characteristics. Logistic regression with progressive adjustment and comprehensive subgroup analyses were conducted to assess associations between transplantation and stone composition. Results: After propensity score matching, transplant recipients with nephrolithiasis demonstrated markedly different stone composition patterns compared to controls. Before matching, carbonate apatite stones were substantially more prevalent among stone formers in the transplant group (37.7% vs. 16.4%, p<0.001), while calcium oxalate monohydrate stones were less common (39.1% vs. 63.7%). After matching with 139 controls, these differences persisted and intensified (carbonate apatite: 37.7% vs. 15.8%; calcium oxalate monohydrate: 39.1% vs. 66.9%, p=0.001). Renal transplantation with nephrolithiasis was associated with significantly lower proportion of calcium oxalate stones compared to non-transplant stone formers (OR 0.32, 95% CI: 0.17-0.57, p<0.001) and significantly higher odds of carbonate apatite stones (OR 3.22, 95% CI: 1.66-6.32, p<0.001).These associations remained robust across sensitivity analyses with progressive adjustment for confounders (adjusted OR for carbonate apatite: 2.82, 95% CI: 1.37-5.82) and multiple subgroups stratified by age, sex, and comorbidities. Additional factors associated with carbonate apatite included renal atrophy (OR 4.37, 95% CI: 1.49-13.17, p=0.007) and urinary tract stricture (OR 2.50, 95% CI: 1.06-5.75, p=0.032). Transplant recipients with nephrolithiasis also exhibited higher proportions of mixed stone composition (58.0% vs. 39.6%, p=0.018) and urological complications. Conclusions: Renal transplantation fundamentally alters urinary stone pathogenesis in patients who develop stones, with distinct compositional shifts toward carbonate apatite and away from calcium oxalate stones. These findings suggest the need for transplant-specific stone prevention protocols.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.